PGEN
Precigen Inc
Halal Rating :
Last Price
$1.11
Last updated:
Market Cap
-
7D Change
3.74%
1 Year Change
-17.16%
Company Overview
Industries
Exchange
Next Earnings Date
Precigen Inc is a biopharmaceutical company specializing in the development of innovative gene and cell therapies. The company utilizes proprietary technologies to develop treatments for various diseases, including cancer, autoimmune disorders, and rare diseases. Their primary focus is on advancing precision medicine through genetic engineering and synthetic biology platforms.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $953000.0 | $22.21m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $1.43m | $63.19m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $1.06m | $25.48m | - | $2000.0 | 0.00% | 0.01% |
Company Impact
Help us evaluate Precigen Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.